Use of glucocorticoids and azithromycin in the therapy of COVID-19.

Autor: de Lemos Neto M; Faculty of Medicine of Campos dos Goytacazes, Av. Alberto Torres, 217, Campos dos Goytacazes, Brazil., Alexandre RCV; Department of Pharmacology, Federal University of the State of Rio de Janeiro, Rio de Janeiro, Brazil., Morra ROG; Department of Pharmacology, Federal University of the State of Rio de Janeiro, Rio de Janeiro, Brazil., da Paz JAS; Molecular Biology Laboratory, Biomedical Research Institute, Marcílio Dias Navy Hospital, Rio de Janeiro, Brazil., Barroso SPC; Molecular Biology Laboratory, Biomedical Research Institute, Marcílio Dias Navy Hospital, Rio de Janeiro, Brazil., Resende AC; Department of Pharmacology, Institute of Biology, Rio de Janeiro State University, Rio de Janeiro, Brazil., de Medeiros-Lima DJM; Faculty of Medicine of Campos dos Goytacazes, Av. Alberto Torres, 217, Campos dos Goytacazes, Brazil. daniel.jose@fmc.br., Alexandre PCB; Department of Pharmacology, Federal University of the State of Rio de Janeiro, Rio de Janeiro, Brazil.

Publikováno v: Pharmacological reports : PR [Pharmacol Rep] 2021 Dec; Vol. 73 (6), pp. 1513-1519. Date of Electronic Publication: 2021 Jun 04.